Search

Your search keyword '"Lindstedt, S."' showing total 671 results

Search Constraints

Start Over You searched for: Author "Lindstedt, S." Remove constraint Author: "Lindstedt, S."
671 results on '"Lindstedt, S."'

Search Results

351. [Vacuum-assisted closure yields good clinical results. Good healing in complicated wounds--deep sternal infections an example].

352. Evaluation of continuous and intermittent myocardial topical negative pressure.

353. Early fetal gene delivery utilizes both central and peripheral mechanisms of tolerance induction.

354. Impact of different topical negative pressure levels on myocardial microvascular blood flow.

355. No hypoperfusion is produced in the epicardium during application of myocardial topical negative pressure in a porcine model.

356. The effect of different topical negative pressures on microvascular blood flow in reperfused myocardium during hypothermia.

357. Blood flow changes in normal and ischemic myocardium during topically applied negative pressure.

358. Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors.

359. Chronic cold exposure increases skeletal muscle oxidative structure and function in Monodelphis domestica, a marsupial lacking brown adipose tissue.

360. Clinical heterogeneity and molecular findings in five Polish patients with glycerol kinase deficiency: investigation of two splice site mutations with computerized splice junction analysis and Xp21 gene-specific mRNA analysis.

361. The positive effects of negative work: increased muscle strength and decreased fall risk in a frail elderly population.

362. Glycerol metabolism and the determination of triglycerides--clinical, biochemical and molecular findings in six subjects.

363. Use of allometry in predicting anatomical and physiological parameters of mammals.

364. Human aerobic performance: too much ado about limits to V(O(2)).

365. Cytotoxic treatment of adrenocortical carcinoma.

366. Shaking up glycolysis: Sustained, high lactate flux during aerobic rattling.

367. Cold exposure increases running VO(2max) and cost of transport in goats.

368. Nontransplant treatment of tyrosinemia.

369. Is the spring quality of muscle plastic?

370. Eccentric ergometry: increases in locomotor muscle size and strength at low training intensities.

371. NTBC as palliative treatment in chronic tyrosinaemia type I.

372. Chronic eccentric exercise: improvements in muscle strength can occur with little demand for oxygen.

373. Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).

374. Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up.

375. Task-specific design of skeletal muscle: balancing muscle structural composition.

377. Human 4-hydroxyphenylpyruvate dioxygenase gene (HPD).

379. Pivalic acid-induced carnitine deficiency and physical exercise in humans.

380. Minimal cost per twitch in rattlesnake tail muscle.

381. The whistle and the rattle: the design of sound producing muscles.

382. Structural correlates of speed and endurance in skeletal muscle: the rattlesnake tailshaker muscle

383. Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).

384. Transient reduction of human left ventricular mass in carnitine depletion induced by antibiotics containing pivalic acid.

385. Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.

386. Effect of short-term treatment with pivalic acid containing antibiotics on serum carnitine concentration--a risk irrespective of age.

387. Hormones, body composition and cardiovascular risk.

388. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters.

389. Fatigue and the design of the respiratory system.

390. Regional assignment of the human 4-hydroxyphenylpyruvate dioxygenase gene (HPD) to 12q24-->qter by fluorescence in situ hybridization.

391. Capillary blood transit time in muscles in relation to body size and aerobic capacity.

392. Impaired ketogenesis in carnitine depletion caused by short-term administration of pivalic acid prodrug.

393. Exercise performance of mammals: an allometric perspective.

394. Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase.

395. Swedish obese subjects (SOS)--an intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined.

396. Human 4-hydroxyphenylpyruvate dioxygenase. Primary structure and chromosomal localization of the gene.

397. gamma-Butyrobetaine hydroxylase. Structural characterization of the Pseudomonas enzyme.

398. Adrenocortical carcinoma--diagnostic and therapeutical implications.

399. Limits to maximal performance.

400. Mitochondrial ATP-synthase deficiency in a child with 3-methylglutaconic aciduria.

Catalog

Books, media, physical & digital resources